CD138 (Syndecan-1) Antibody (Immunohistochemistry)

CD138 (Syndecan-1) Antibody (Immunohistochemistry)

The CD138 (Syndecan-1) Antibody is a transmembrane heparan sulfate proteoglycan marker expressed primarily on plasma cells and epithelial tissues.
It plays an essential role in cell proliferation, migration, adhesion, and extracellular matrix interactions, serving as a key diagnostic marker for plasma cell neoplasms.

In immunohistochemistry, CD138 shows brown membranous and cytoplasmic staining in positive cells, making it highly effective for identifying Multiple Myeloma, Plasmacytoma, and related disorders.

🔬 Features and Benefits CD138 (Syndecan-1) Antibody

• Specific marker for plasma cells and related neoplasms

• Distinct membranous/cytoplasmic brown staining pattern

• Applicable for diagnosing Multiple Myeloma and Plasmacytoma

• Compatible with FFPE tissues and DAB chromogen systems

• Excellent stability: 18-month shelf life at 2–8 °C

💡 Diagnostic Applications

• Detection of Plasma Cell Neoplasms (Multiple Myeloma, Plasmacytoma)

• Differentiation between Lymphoma and Myeloma

• Research on cell adhesion and extracellular matrix function

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of Talent Biomedical in Iran, supplies high-quality immunohistochemistry antibodies, including CD138 (Syndecan-1).
With a focus on scientific accuracy, diagnostic precision, and international standards, Fardad Azma Rad supports pathology and molecular diagnostic laboratories across Iran.

“Download Brochure”